表紙
市場調查報告書

鼻腔給藥技術的全球市場 - 至2021年的預測:噴鼻劑,噴霧,粉末,凝膠

Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 544751
出版日期 內容資訊 英文 212 Pages
訂單完成後即時交付
價格
鼻腔給藥技術的全球市場 - 至2021年的預測:噴鼻劑,噴霧,粉末,凝膠 Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) - Global Forecast to 2021
出版日期: 2017年01月11日內容資訊: 英文 212 Pages
簡介

全球鼻腔給藥技術市場,預計從2016年的440億美元,到2021年擴大到642億美元。預計市場2016年∼2021年以6.5%的年複合成長率成長。

本報告提供全球鼻腔給藥技術市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會
    • 課題

第6章 法規方案

第7章 鼻腔給藥技術的全球市場:各投藥形態

  • 簡介
  • 鼻噴霧
  • 滴鼻劑、液體
  • 鼻凝膠
  • 鼻粉末
  • 其他

第8章 鼻腔給藥技術的全球市場:各容器

  • 簡介
  • 非加壓容器
  • 加壓容器

第9章 鼻腔給藥技術的全球市場:各系統

  • 簡介
  • 多劑量
  • 2次給藥
  • 單位用量

第10章 鼻腔給藥技術的全球市場:各治療應用

  • 簡介
  • 過敏性/非過敏性鼻炎
  • 鼻塞
  • 疫苗接種
  • 其他

第11章 鼻腔給藥技術的全球市場:各終端用戶

  • 簡介
  • 醫院
  • 居家醫療

第12章 鼻腔給藥技術的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞洲
  • 其他

第13章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭情形與趨勢

第14章 企業簡介

  • 簡介
  • MERCK & CO., INC.
  • NOVARTIS AG
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON SERVICES, INC.
  • PFIZER INC.
  • ASTRAZENECA PLC
  • APTARGROUP, INC.
  • AEGIS THERAPEUTICS LLC
  • 3M
  • BECTON, DICKINSON AND COMPANY

第15章 附錄

目錄
Product Code: MD 4892

The global nasal drug delivery technology market is projected to reach USD 64.20 billion by 2021 from USD 44.00 billion in 2016, at a CAGR of 6.5% during the forecast period.

Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing self-administration practices among the patients are the factors driving the growth of this market. Whereas, growth among over-the-counter nasal drugs and increasing focus on alternative routes of drug delivery such as nasal drug delivery offer significant growth opportunities for players operating in this market. On the other hand, complications associated with the overuse of nasal sprays may restraint the growth of the market.

The nasal drug delivery technology market is segmented based on dosage form, therapeutic application, end user, system, container, and region. On the basis of container, the market is segmented into pressurized and non-pressurized containers. In 2016, the non-pressurized containers segment is expected to account for the largest share of the market. The large share of this segment can primarily be attributed to advantages such as better versatility and reliability, instant availability, self-containment, better portability, and low-cost medical aerosol delivery. In addition, the increasing usage of these devices for the treatment of asthma and chronic obstructive pulmonary disease (COPD) is expected to further drive the growth of this market in the coming years.

On the basis of end user, the market is segmented into hospitals and home care settings. In 2016, the home care settings segment is expected to account for the largest share of the market, primarily due to the increasing preference for self-administration among patients.

Asia is expected to be fastest-growing region in the nasal drug delivery technology market from 2016 to 2021. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.

Prominent players in the nasal drug delivery technology market include Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Pfizer, Inc. (U.S.), AstraZeneca plc. (U.S.), AptarGroup (U.S.), and GlaxoSmithKline plc (U.K.).

Research Coverage:

The report defines, describes, and forecast the nasal drug delivery technology market on the basis of dosage form, therapeutic application, end user, system, container, and region. It provides detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, challenges). The study tracks and analyzes competitive developments such as joint ventures, mergers and acquisitions, new product developments, and expansions in the nasal drug delivery technology market across to four main regions, namely, North America, Asia, Europe, and the Rest of the World (RoW).

Reasons to Buy the Report:

The report on the nasal drug delivery technology market provides quantitative information for clients seeking market size information on various segments of this market. This report also provides access to the quantitative data on the nasal drug delivery technology market. This report covers -

  • Current and forecast assessment of the nasal drug delivery technology market.
  • Country-wise assessment of each of the segments
  • Global market share analysis for major segments of the nasal drug delivery technology market
  • Adoption trends of various nasal drug delivery technologies for major geographic markets
  • Five-year coverage of strategic developments of top players in the nasal drug delivery technology market
  • Product Portfolio mapping of leading players in the nasal drug delivery technology market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
  • 1.4. LIMITATIONS
  • 1.5. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY DATA POINT FROM SECONDARY SOURCES
  • 2.4. KEY DATA POINT FROM PRIMARY SOURCES
  • 2.5. KEY INDUSTRY INSIGHTS
  • 2.6. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. MARKET DRIVERS
      • 5.3.1.1. Increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy
      • 5.3.1.2. Growing adoption of self-administration practices
    • 5.3.2. MARKET RESTRAINTS
      • 5.3.2.1. Complications associated with the overuse of nasal sprays
    • 5.3.3. MARKET OPPORTUNITIES
      • 5.3.3.1. Over-the-counter nasal drugs
      • 5.3.3.2. Increasing focus on alternative routes such as nasal drug delivery
    • 5.3.4. MARKET CHALLENGES
      • 5.3.4.1. Regulatory hurdles

6. REGULATORY SCENARIO

7. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM

  • 7.1. INTRODUCTION
  • 7.2. NASAL SPRAY
  • 7.3. NASAL DROPS AND LIQUIDS
  • 7.4. NASAL GELS
  • 7.5. NASAL POWDERS
  • 7.6. OTHERS

8. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY CONTAINERS

  • 8.1. INTRODUCTION
  • 8.2. NON-PRESSURIZED CONTAINERS
  • 8.4. PRESSURIZED CONTAINERS

9. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY SYSTEMS

  • 9.1. INTRODUCTION
  • 9.2. MULTI DOSE
  • 9.3. BI-DOSE
  • 9.4. UNIT DOSE

10. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY THERAPEUTIC APPLICATION

  • 10.1. ALLERGIC AND NON-ALLERGIC RHINITIS
  • 10.2. NASAL CONGESTION
  • 10.3. VACCINATIONS
  • 10.5. OTHER APPLICATIONS

11. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY END USER

  • 11.1. INTRODUCTION
  • 11.2. HOSPITALS
  • 11.3. HOME HEALTH CARE

12. GEOGRAPHIC ANALYSIS

  • 12.1. INTRODUCTION
  • 12.2. NORTH AMERICA
    • 12.2.1. U.S.
    • 12.2.2. CANADA
  • 12.3. EUROPE
    • 12.3.1. GERMANY
    • 12.3.2. FRANCE
    • 12.3.3. U.K.
    • 12.3.4. REST OF THE EUROPE (ROE)
  • 12.4. ASIA
    • 12.4.1. JAPAN
    • 12.4.2. INDIA
    • 12.4.3. CHINA
    • 12.4.4. ROA
  • 12.5. REST OF THE WORLD (ROW)

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. MARKET SHARE ANALYSIS
  • 13.3. COMPETITIVE SITUATIONS & TRENDS

14. COMPANY PROFILES*

  • 14.1. INTRODUCTION
  • 14.2. MERCK & CO., INC.
  • 14.3. NOVARTIS AG
  • 14.4. GLAXOSMITHKLINE PLC
  • 14.5. JOHNSON & JOHNSON SERVICES, INC.
  • 14.6. PFIZER INC.
  • 14.7. ASTRAZENECA PLC
  • 14.8. APTARGROUP, INC.
  • 14.9. AEGIS THERAPEUTICS LLC
  • 14.10. 3M
    • 14.10.4. MNM VIEW
  • 14.11. BECTON, DICKINSON AND COMPANY

The segment/chapters will be added according to the availability of the information.

*Tentative list of companies added, This is subjected to the addition and deletion of companies.

15. APPENDIX

  • 15.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 15.2. DISCUSSION GUIDE
  • 15.3. KNOWLEDGE STORE
  • 15.4. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 15.5. RELATED REPORTS
  • 15.6. AUTHORS DETAILS

LIST OF TABLES

  • TABLE 1: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 2: NASAL SPRAYS DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 3: NASAL DROPS & LIQUIDS DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: NASAL DROPS & LIQUIDS DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: NASAL DRUG DELIVERY MARKET SIZE, BY CONTAINER TYPE, 2014-2021 (USD MILLION)
  • TABLE 6: NASAL DRUG DELIVERY MARKET SIZE FOR NON-PRESSURIZED CONTAINERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: NASAL DRUG DELIVERY MARKET SIZE FOR PRESSURIZED CONTAINERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 9: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR MULTI-DOSE SYSTEMS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR BI-DOSE SYSTEMS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR UNIT-DOSE SYSTEMS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: NASAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 13: NASAL DRUG DELIVERY MARKET SIZE FOR ALLERGIC AND NON-ALLERGIC RHINITIS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: NASAL DRUG DELIVERY MARKET SIZE FOR NASAL CONGESTION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: NASAL DRUG DELIVERY MARKET SIZE FOR VACCINATION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: NASAL DRUG DELIVERY MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: NASAL DRUG DELIVERY MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: NASAL DRUG DELIVERY MARKET SIZE FOR HOMECARE SETTINGS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NASAL DRUG DELIVERY MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 26: NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 27: U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 28: U.S.: NASAL DRUG DELIVERY MARKET, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 29: U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 30: U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 31: U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 32: CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION
  • TABLE 33: CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 34: CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 35: CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 36: CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 37: EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 38: EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 39: EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 40: EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 41: EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 42: GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 43: GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 44: GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 45: GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 46: GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 47: U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 48: U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 49: U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 50: U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 51: U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 52: FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 53: FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 54: FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 55: FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 56: FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 57: ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 58: ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 59: ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 60: ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 61: ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 62: ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 63: ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 64: ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 65: ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 66: ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 67: JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 68: JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 69: JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 70: JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 71: JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 72: CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 73: CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 74: CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 75: CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 76: CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 77: INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 78: INDIA: NASAL DRUG DELIVERY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 79: INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 80: INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 81: INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 82: ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 83: ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 84: ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 85: ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION
  • TABLE 86: ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 87: ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 88: ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD MILLION)
  • TABLE 89: ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 90: ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014-2021 (USD MILLION)
  • TABLE 91: ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 92: PRODUCT LAUNCHES AND APPROVALS, 2014-2016
  • TABLE 93: COLLABORATIONS, 2014-2016
  • TABLE 94: EXPANSIONS, 2014-2016
  • TABLE 95: MARKET RANKING FOR THE KEY PLAYERS IN 2016

LIST OF FIGURES

  • FIGURE 1: SEGMENTATION & COVERAGE
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: NASAL DRUG DELIVERY MARKET: TOP DOWN APPROACH
  • FIGURE 4: NASAL DRUG DELIVERY MARKET: BOTTOM UP APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: ASSUMPTIONS FOR THE STUDY
  • FIGURE 7: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2016 VS. 2021
  • FIGURE 8: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY SYSTEMS, 2016 VS. 2021
  • FIGURE 9: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY END USER, 2016 VS. 2021
  • FIGURE 10: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY THERAPEUTIC APPLICATION, 2016 VS. 2021
  • FIGURE 11: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY CONTAINER, 2016 VS. 2021
  • FIGURE 12: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY REGION, 2016-2021
  • FIGURE 13: NASAL DRUG DELIVERY TECHNOLOGY MARKET TO SHOWCASE LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 14: HOME CARE SETTINGS SEGMENT IS EXPECTED TO GROW AT A HIGHEST CAGR, BY END USER, (2016-2021)
  • FIGURE 15: MULTI-DOSE SYSTEMS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET, BY SYSTEM, IN 2016
  • FIGURE 16: ALLERIC AND NON-ALLERGIC RHINITIS TO DOMINATE THE MARKET, BY THERAPEUTIC APPLICATION, IN 2016
  • FIGURE 17: NASAL DRUG DELIVERY TECHNOLOGY MARKET IN JAPAN TO REGISTER THE HIGHEST CAGR (2016-2021)
  • FIGURE 18: NASAL DRUG DELIVERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 20: EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 21: ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 22: KEY PLAYERS ADOPTED ORGANIC AND INORGANIC GROWTH STRATEGIES BETWEEN 2014 AND 2016
  • FIGURE 23: MARKET EVOLUTION FRAMEWORK
  • FIGURE 24: BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES AND APPROVALS-KEY STRATEGIES ADOPTED BY MARKET PLAYERS
  • FIGURE 25: GEOGRAPHIC REVENUE MIX OF TOP FIVE MARKET PLAYERS (2015)
  • FIGURE 26: MERCK & CO., INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 27: NOVARTIS AG: COMPANY SNAPSHOT (2015)
  • FIGURE 28: GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2015)
  • FIGURE 29: JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 30: PFIZER, INC: COMPANY SNAPSHOT (2015)
  • FIGURE 31: ASTRAZENECA PLC: COMPANY SNAPSHOT (2015)
  • FIGURE 32: APTARGROUP, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 33: AEGIS THERAPEUTICS, LLC: COMPANY SNAPSHOT (2015)
  • FIGURE 34: 3M: COMPANY SNAPSHOT (2015)
  • FIGURE 35: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2015)
  • FIGURE 36: INSIGHTS FROM INDUSTRY EXPERTS